Morgan Stanley Turns 'Underweight' On Divi's Laboratories | Halftime Report | CNBC-TV18

Morgan Stanley has initiated coverage on drugmaker Divi's Laboratories with an underweight rating, citing rich valuations on the stock. The firm gave a price target of Rs 3,053 on the stock, implying a potential downside of 11 percent from Thursday's closing price. #morganstanley #divislab #brokerageview #businessnews #businessnewstoday #businessnewsinenglish #sharemarkettoday #cnbctv18 About CNBC-TV18: India's leading business news channel, CNBC-TV18 offers the most comprehensive coverage of businesses, the economy and the financial markets. Catch all your favourite shows, exclusive videos, big-ticket interviews and more here. You can also connect with CNBC-TV18 News Online Catch the latest news: https://bit.ly/2YbpXBM Follow CNBC-TV18 round the clock: https://www.cnbctv18.com/live-tv/ Stay updated with all the market action in real time: https://www.cnbctv18.com/market-live/ You can also stay updated with all the latest news on-the-go with CNBC-TV18 Minis: https://www.cnbctv18.com/minis/ Subscribe to our Channel: https://bit.ly/3nvEcxf Like us on Facebook:   / cnbctv18india   Follow us on Twitter:   / cnbctv18news   n18oc_business